PHARMAROCK INTERNATIONAL: what changed
What changed
PHARMAROCK INTERNATIONAL
NACE 46.180, Agents specialised in the wholesale of other particular products
filed annual accounts (NBB)
Net result for the year
€77,208
2024 · €84,017-€6,809
Equity
€495,863
2024 · €477,769+€18,094
Cash
€283,309
2024 · €254,966+€28,343
Balance sheet total
€504,618
2024 · €489,612+€15,007
Largest movements
Assets
- Cash +€28,343
up €28,343 (+11.1%), from €254,966 to €283,309
mainly Net result for the year (+€77,208) and Depreciation (+€15,139)
- Tangible fixed assets -€13,336
down €13,336 (-6.2%), from €216,294 to €202,958
of which Land and buildings: -€14,803
Equity and liabilities
- Reserves +€18,094
up €18,094 (+3.9%), from €458,804 to €476,898
Income statement
- Gross operating margin -€7,768
down €7,768 (-5.9%), from €131,519 to €123,751
- Taxes -€3,130
down €3,130 (-9.6%), from €32,541 to €29,411
- Financial income -€1,652
down €1,652 (-74.5%), from €2,218 to €566
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€84,017
Gross operating margin
-€7,768
Depreciation
-€390
Other operating charges
-€142
Financial income
-€1,652
Financial charges
+€11
Taxes
+€3,130
Result 2025
€77,208
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€89,260
Investment
-€1,803
Financing
-€59,114
Cash 2024
€254,966
From operations (derived)
+€89,260
Net result for the year
+€77,208
Depreciation
+€15,139
Smaller working-capital items
+€5
Tax, wage and social debts
-€3,092
Investment (derived)
-€1,803
Investment in fixed assets (net)
-€1,803
Financing
-€59,114
Contributions, distributions and other
-€59,114
Cash 2025
€283,309
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €489,612 | €504,618 | +€15,007 | +3.1% |
| Fixed assets | 21/28 | €216,294 | €202,958 | -€13,336 | -6.2% |
| Tangible fixed assets | 22/27 | €216,294 | €202,958 | -€13,336 | -6.2% |
| Land and buildings | 22 | €214,094 | €199,291 | -€14,803 | -6.9% |
| Plant, machinery and equipment | 23 | €2,200 | €2,200 | = | 0.0% |
| Furniture and vehicles | 24 | - | €1,466 | +€1,466 | |
| Current assets | 29/58 | €273,318 | €301,661 | +€28,343 | +10.4% |
| Amounts receivable within one year | 40/41 | €18,150 | €18,150 | = | 0.0% |
| Trade receivables | 40 | €18,150 | €18,150 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €254,966 | €283,309 | +€28,343 | +11.1% |
| Deferred charges and accrued income | 490/1 | €201 | €202 | +€0 | +0.2% |
| Total equity and liabilities | 10/49 | €489,612 | €504,618 | +€15,007 | +3.1% |
| Equity | 10/15 | €477,769 | €495,863 | +€18,094 | +3.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €458,804 | €476,898 | +€18,094 | +3.9% |
| Distributable reserves | 133 | €458,804 | €476,898 | +€18,094 | +3.9% |
| Profit (loss) carried forward | 14 | €366 | €366 | = | 0.0% |
| Amounts payable | 17/49 | €11,842 | €8,755 | -€3,087 | -26.1% |
| Amounts payable within one year | 42/48 | €11,842 | €8,755 | -€3,087 | -26.1% |
| Trade debts | 44 | €1,455 | €1,460 | +€5 | +0.3% |
| Suppliers | 440/4 | €1,455 | €1,460 | +€5 | +0.3% |
| Taxes, remuneration and social security | 45 | €10,354 | €7,262 | -€3,092 | -29.9% |
| Taxes | 450/3 | €10,354 | €7,262 | -€3,092 | -29.9% |
| Other amounts payable | 47/48 | €34 | €34 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,750 | €15,139 | +€390 | +2.6% |
| Other operating charges | 640/8 | €2,150 | €2,292 | +€142 | +6.6% |
| Gross operating margin | 9900 | €131,519 | €123,751 | -€7,768 | -5.9% |
| Operating profit (loss) | 9901 | €114,618 | €106,319 | -€8,299 | -7.2% |
| Financial income | 75/76B | €2,218 | €566 | -€1,652 | -74.5% |
| Recurring financial income | 75 | €2,218 | €566 | -€1,652 | -74.5% |
| Financial charges | 65/66B | €277 | €266 | -€11 | -4.1% |
| Recurring financial charges | 65 | €277 | €266 | -€11 | -4.1% |
| Profit (loss) for the period before taxes | 9903 | €116,559 | €106,619 | -€9,939 | -8.5% |
| Income taxes | 67/77 | €32,541 | €29,411 | -€3,130 | -9.6% |
| Profit (loss) for the period | 9904 | €84,017 | €77,208 | -€6,809 | -8.1% |
| Profit (loss) for the period to be appropriated | 9905 | €84,017 | €77,208 | -€6,809 | -8.1% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.